There is extensive evidence showing that the intake of healthy fats can reduce incidence of cardiovascular disease (CVD). Dr. Frank Hu of the Harvard T.H. Chan School of Public Health and professor of medicine at Harvard Medical School discusses the evidence from several studies showing the benefits of healthy oils and fats for reduction of CVD incidence and CVD risk factors. Overall recommendations include keeping intake of saturated fatty acids low, replace saturated fat with unsaturated fats, and consume mono-unsaturated…

Part two of Dr. Penny Kris-Etherton’s presentation entitled Clinical Evidence Supporting the Role of Healthy Fats to Reduce Cardiovascular (CVD) Risk Factors is shown in this presentation. Here, Dr. Kris-Etherton discusses more clinical trial evidence regarding the support of unsaturated fatty acids, new research on minor fatty acids, and how these recommendations can be applied to dietary patterns in the real world. The role of the Mediterranean Diet in preventing cardiovascular disease was investigated in several studies, with additional focus…

This presentation is the first in a two-part series on healthy fats and fatty acids presented by Penny Kris-Etherton, PhD, RD of the Department of Nutritional Sciences at Penn State University. In this part of the presentation, she discusses current dietary recommendations and popular opinions. Published just before the release of the 2015 USDA Dietary Guidelines, the presentation provides advice related to macronutrient balance for consumers, with special attention given to total fat, saturated fat, and cholesterol. Patients and practitioners…

This webinar is by Osama Hamdy, MD is the medical director of the obesity clinical program at the Joslin Diabetes Center in Boston. He is also a professor of medicine at Harvard Medical School and works in the inpatient clinic at Joslin. He also created Joslin’s Why Wait program. This presentation is entitled, “The Reality of Carbohydrate Intolerance” and is the first of five webinars by Dr. Hamdy on the clinical management of obese and diabetic patients. The webinar focuses…

This webinar is by Dr. Osama Hamdy, the medical director of the obesity clinical program at the Joslin Diabetes Center in Boston. He is also a professor of medicine at Harvard Medical School and works in the inpatient clinic at Joslin. He also created Joslin’s Why Wait program. This presentation is entitled, “The National Nutrition Fat Experiment: Was it Successful?” and is the second of five presentations by Dr. Hamdy on the clinical management of obese and diabetic patients. The…

This presentation by Dr. Osama Hamdy of the Joslin Diabetes Center in Boston, MA discusses the myth and the facts of protein intake. In general, for diabetic patients with normal renal function, protein should make up 15-20% of total energy intake and high protein diets are generally not recommended for diabetes patients. Dr. Hamdy also discusses the relationship between protein intake and kidney function in diabetic patients. Watching this presentation will shed light on the origin of protein recommendations and…

This webinar is by Osama Hamdy, MD, PhD and is entitled “Medical Nutrition Therapy for Prevention and Management of Diabetes.” Dr. Hamdy is the Medical director of the Obesity Clinical Program and Director of Inpatient Diabetes Management at the Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. This is the fourth webinar in a series of five on Take Control – a series focused on blood glucose. Medical Nutrition Therapy is the use of nutrition…

This webinar is entitled “Optimal Lifestyle Intervention for Patients with Diabetes: The Joslin Why WAIT Model.” It is delivered by Osama Hamdy, the Medical Director of the Obesity Clinical Program at the Joslin Diabetes Center in Boston, and also the creator of the Why WAIT program, clinically proven to support weight loss and glucose control among diabetic patients. The “WAIT” in Why Wait stands for Weight Achievement and Intensive Treatment. It is a 12-week multidisciplinary program for weight control and…

This webinar Dr. Osama Hamdy, the medical director of the obesity program at the Joslin Diabetes Center. This presentation is entitled, “Nutrition Revolution in the Prevention and Management of Obesity and Diabetes” and discusses the pathology of diabetes, specifically why it is the result of carbohydrate intolerance and glucose toxicity. Furthermore, he discusses the role of micronutrients and demonstrates the evidence for medical nutrition therapy. A major risk factor for diabetes is obesity, but independent of obesity and BMI, elevated…

by Bianca Garilli, ND Sleep plays an important role in foundational health with inadequate amounts contributing to risks associated with obesity, type 2 diabetes (T2D), metabolic syndrome, hypertension and cardiovascular disease.1 One study reviewing the relationship between insufficient sleep and chronic health issues concluded, “Sleep duration of less than 6 hours is a risky behavior for the development of chronic diseases, particularly stroke and cancer, and should be therefore addressed in public health campaigns.”2 Studies have shown that the risk…